News & Updates

Myocarditis, pericarditis not uncommon with mRNA-1273 COVID-19 vaccines
Myocarditis, pericarditis not uncommon with mRNA-1273 COVID-19 vaccines
26 Nov 2022

Although the incidence of myocarditis or pericarditis following mRNA COVID-19 vaccination is low, a two- to threefold higher likelihood is seen among individuals who received mRNA-1273 compared to BNT162b2 vaccine, reveals a study.

Myocarditis, pericarditis not uncommon with mRNA-1273 COVID-19 vaccines
26 Nov 2022
Lower all-cause death, fewer HF events with empagliflozin in acute HF
Lower all-cause death, fewer HF events with empagliflozin in acute HF
25 Nov 2022 byRoshini Claire Anthony

Patients hospitalized with acute heart failure (HF) have a reduced risk of subsequent HF events or all-cause mortality if treated with once-daily empagliflozin while in hospital, according to results of the EMPULSE trial presented at HFSA 2022.

Lower all-cause death, fewer HF events with empagliflozin in acute HF
25 Nov 2022
Fatigue worsens quality of life, productivity in patients with psoriatic arthritis
Fatigue worsens quality of life, productivity in patients with psoriatic arthritis
25 Nov 2022 byStephen Padilla

Patients with psoriatic arthritis (PsA) usually complain of fatigue, which is less frequently diagnosed by many physicians, reports a study. Severe fatigue may lead to poorer physical functioning, work productivity, and health-related quality of life (HRQOL).

Fatigue worsens quality of life, productivity in patients with psoriatic arthritis
25 Nov 2022